← Leaderboards
Charles Dimmler III
Ceramedix Holding, Llc
$4,223,612
Attributed
$4,223,612
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$4,223,612 · 1
By mechanism
N01$4,223,612 · 1
Top collaborators
No co-investigators on record.
Most similar at Ceramedix Holding, Llc
Same institution · by research overlap
- Galina Vid$3,007,043
- Arthur Tinkelenberg$994,084
Others in their field
Other Rising Stars on “Acute”
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Christopher J. Lindsell · Vanderbilt University Medical Center$8,536,327
- Michael E. Roth · Public Health Institute$8,201,777
- Jacob Sutton Coverstone · Neurovations$6,882,205
- Agustin G Yip · Albert Einstein College Of Medicine$6,090,308
Research focus
AcuteAnimal ExperimentationApoptosisBiologicalBiomarker DevelopmentBlood VesselsCessation Of LifeEndotheliumFda ApprovedFemaleGastrointestinalInjuryIonizing RadiationIrradiationMaleMedical CountermeasureOrgan FailurePegfilgrastimRadiationRadiation AccidentsRadiation EffectRadiation ExposureRadiation-Induced InjuryRadiation Injuries
Grant awards (3)
DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE$1,267,019
N01 · FY2025 · AI · contact PI
DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE$1,427,108
N01 · FY2024 · AI · contact PI
DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE$1,529,485
N01 · FY2023 · AI · contact PI